{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:36Z","timestamp":1790423256347,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.humimm.2024.110800","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T15:58:15Z","timestamp":1712678295000},"page":"110800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Updates in induction immunosuppression regimens for intestinal transplantation"],"prefix":"10.1016","volume":"85","author":[{"given":"Johann","family":"Paulo Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Maklad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat","family":"Elsherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-0081","authenticated-orcid":false,"given":"Masato","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.humimm.2024.110800_b0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/SLA.0b013e3181b67725","article-title":"Five hundred intestinal and multivisceral transplantations at a single center: Major advances with new challenges","volume":"250","author":"Abu-Elmagd","year":"2009","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.humimm.2024.110800_b0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjsurg.2008.04.025","article-title":"New directions for induction immunosuppression strategy in solid organ transplantation","volume":"197","author":"Hawksworth","year":"2009","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.humimm.2024.110800_b0015","doi-asserted-by":"crossref","unstructured":"K. Abu-Elmagd. The history of intestinal transplantation. History of Organ and Cell Transplantation. 2003 171.","DOI":"10.1142\/9781848160057_0008"},{"issue":"8670","key":"10.1016\/j.humimm.2024.110800_b0020","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(89)91014-3","article-title":"FK 506 for liver, kidney, and pancreas transplantation","volume":"334","author":"Starzl","year":"1989","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.humimm.2024.110800_b0025","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nri2200","article-title":"Specificity of T-cell alloreactivity","volume":"7","author":"Felix","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5528","key":"10.1016\/j.humimm.2024.110800_b0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1062946","article-title":"The art of the probable: System control in the adaptive immune system","volume":"293","author":"Germain","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.humimm.2024.110800_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1600-065X.2003.00082.x","article-title":"Heterologous immunity: An overlooked barrier to tolerance","volume":"196","author":"Adams","year":"2003","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.humimm.2024.110800_b0040","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance","volume":"111","author":"Adams","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.humimm.2024.110800_b0045","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1097\/TP.0000000000003074","article-title":"Association of more intensive induction with less acute rejection following intestinal transplantation: results of 445 consecutive cases from a single center","volume":"104","author":"Vianna","year":"2020","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.humimm.2024.110800_b0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2024.110800_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0966-3274(00)00021-6","article-title":"Daclizumab (Zenapax\u00ae) inhibits early interleukin-2 receptor signal transduction events","volume":"8","author":"Goebel","year":"2000","journal-title":"Transpl. Immunol."},{"issue":"1461","key":"10.1016\/j.humimm.2024.110800_b0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1098\/rstb.2005.1702","article-title":"CAMPATH: from concept to clinic","volume":"360","author":"Waldmann","year":"2005","journal-title":"Philos. Trans. R. Soc., B"},{"issue":"12","key":"10.1016\/j.humimm.2024.110800_b0065","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/01.tp.0000296680.75175.67","article-title":"Alemtuzumab","volume":"84","author":"Weaver","year":"2007","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2024.110800_b0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MOT.0000000000000958","article-title":"Update on immunosuppressive strategies in intestinal transplantation","volume":"27","author":"Merola","year":"2022","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"4 Pt 2","key":"10.1016\/j.humimm.2024.110800_b0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1600-6143.2010.03044.x","article-title":"Intestine transplantation in the United States, 1999\u20132008","volume":"10","author":"Mazariegos","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2024.110800_b0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ajt.12979","article-title":"Intestinal transplant registry report: global activity and trends","volume":"15","author":"Grant","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"2 Suppl 1","key":"10.1016\/j.humimm.2024.110800_b0085","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1016\/j.ajt.2023.02.007","article-title":"OPTN\/SRTR 2021 annual data report: Intestine","volume":"23","author":"Horslen","year":"2023","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.humimm.2024.110800_b0090","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/ajt.15269","article-title":"Long-term survival in visceral transplant recipients in the new era: A single-center experience","volume":"19","author":"Elsabbagh","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.humimm.2024.110800_b0095","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1097\/TP.0000000000003081","article-title":"Induction in intestinal transplantation","volume":"104","author":"Gondolesi","year":"2020","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2024.110800_b0100","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1097\/TXD.0000000000001512","article-title":"The first collective examination of immunosuppressive practices among American intestinal transplant centers","volume":"9","author":"Weiner","year":"2023","journal-title":"Transplant. Direct"},{"issue":"9","key":"10.1016\/j.humimm.2024.110800_b0105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/TP.0b013e31816dd450","article-title":"Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation","volume":"85","author":"Vianna","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2024.110800_b0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.transproceed.2009.12.028","article-title":"Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China","volume":"42","author":"Yuan-Xin","year":"2010","journal-title":"Transplant Proc."},{"issue":"6","key":"10.1016\/j.humimm.2024.110800_b0115","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.transproceed.2006.05.057","article-title":"Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients","volume":"38","author":"Nishida","year":"2006","journal-title":"Transplant Proc."},{"issue":"10","key":"10.1016\/j.humimm.2024.110800_b0120","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.tp.0000219235.97036.9c","article-title":"Alemtuzumab (Campath-1H): A systematic review in organ transplantation","volume":"81","author":"Morris","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2024.110800_b0125","first-page":"155","article-title":"A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation","author":"Abu-Elmagd","year":"2012","journal-title":"Clin Transpl."},{"issue":"1","key":"10.1016\/j.humimm.2024.110800_b0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.transproceed.2009.12.019","article-title":"Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period","volume":"42","author":"Zanfi","year":"2010","journal-title":"Transplant Proc."},{"issue":"9","key":"10.1016\/j.humimm.2024.110800_b0135","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/01.TP.0000060250.50591.39","article-title":"Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation","volume":"75","author":"Tzakis","year":"2003","journal-title":"Transplantation"},{"issue":"7S","key":"10.1016\/j.humimm.2024.110800_b0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.tp.0000945572.10771.34","article-title":"29: Significantly reduced acute rejection with steroid-free alemtuzumab induction in intestinal transplantation","volume":"107","author":"Fujiki","year":"2023","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2024.110800_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200427020-00002","article-title":"A benefit-risk assessment of basiliximab in renal transplantation","volume":"27","author":"Boggi","year":"2004","journal-title":"Drug Saf."},{"issue":"6","key":"10.1016\/j.humimm.2024.110800_b0150","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0031-3955(03)00121-4","article-title":"Current immunosuppressive agents: efficacy, side effects, and utilization","volume":"50","author":"Smith","year":"2003","journal-title":"Pediatr. Clin. North Am."},{"issue":"1","key":"10.1016\/j.humimm.2024.110800_b0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14712598.7.1.137","article-title":"The role of basiliximab induction therapy in organ transplantation","volume":"7","author":"Ramirez","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.humimm.2024.110800_b0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.transproceed.2004.01.099","article-title":"Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function","volume":"36","author":"Farmer","year":"2004","journal-title":"Transplant Proc."},{"issue":"3","key":"10.1016\/j.humimm.2024.110800_b0165","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0041-1345(02)02681-7","article-title":"Basiliximab decreases the incidence of acute rejection after intestinal transplantation","volume":"34","author":"Sudan","year":"2002","journal-title":"Transplant Proc."},{"issue":"9","key":"10.1016\/j.humimm.2024.110800_b0170","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/TP.0b013e3182888df0","article-title":"Impact of positive flow cytometry crossmatch on outcomes of intestinal\/multivisceral transplantation: role anti-IL-2 receptor antibody","volume":"95","author":"Kubal","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2024.110800_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3046.2012.01644.x","article-title":"Current status of immunosuppressive agents for solid organ transplantation in children","volume":"16","author":"Coelho","year":"2012","journal-title":"Pediatr. Transplant."},{"issue":"6","key":"10.1016\/j.humimm.2024.110800_b0180","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0041-1345(00)01180-5","article-title":"The efficacy of daclizumab for intestinal transplantation: Preliminary report","volume":"32","author":"Abu-Elmagd","year":"2000","journal-title":"Transplant Proc."},{"issue":"4","key":"10.1016\/j.humimm.2024.110800_b0185","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.TP.0000083042.03188.6C","article-title":"Isolated intestinal transplantation: Proof of clinical efficacy","volume":"76","author":"Fishbein","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2024.110800_b0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin. Hematol."},{"issue":"7S","key":"10.1016\/j.humimm.2024.110800_b0195","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.tp.0000757800.57803.14","article-title":"PE-32: Improved graft survival in liver-free visceral transplantation with strong preformed donor specific antibody","volume":"105","author":"Fujiki","year":"2021","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2024.110800_b0200","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00007890-200211150-00022","article-title":"Monoclonal antibody against beta7 integrins, but not beta7 deficiency, attenuates intestinal allograft rejection in mice","volume":"74","author":"Kellersmann","year":"2002","journal-title":"Transplantation"},{"issue":"6S2","key":"10.1016\/j.humimm.2024.110800_b0205","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1097\/01.tp.0000521457.96829.9e","article-title":"Vedolizumab after intestinal transplantation","volume":"101","author":"Norsa","year":"2017","journal-title":"Transplantation"},{"issue":"6S2","key":"10.1016\/j.humimm.2024.110800_b0210","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.tp.0000521364.18534.8f","article-title":"Vedolizumab for the treatment of refractory severe rejection in intestinal transplantation","volume":"101","author":"Beduschi","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2024.110800_b0215","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1097\/TXD.0000000000000973","article-title":"Safe and successful treatment of acute cellular rejection of an intestine and abdominal wall transplant with vedolizumab","volume":"6","author":"Trentadue","year":"2020","journal-title":"Transplant Direct."},{"issue":"10","key":"10.1016\/j.humimm.2024.110800_b0220","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/ecco-jcc\/jjab058","article-title":"Vedolizumab and anti-tumour necrosis factor alpha real-world outcomes in biologic-naive inflammatory bowel disease patients: Results from the evolve study","volume":"15","author":"Bressler","year":"2021","journal-title":"J. Crohns. Colitis."},{"issue":"3","key":"10.1016\/j.humimm.2024.110800_b0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gut.2007.133322","article-title":"NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine","volume":"57","author":"Fishbein","year":"2008","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.humimm.2024.110800_b0230","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.16283","article-title":"Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab","volume":"21","author":"Kroemer","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.humimm.2024.110800_b0235","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1111\/j.1600-6143.2012.04237.x","article-title":"Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver","volume":"12","author":"Abu-Elmagd","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2024.110800_b0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/TP.0000000000001391","article-title":"Prevalence and clinical impact of donor-specific alloantibody among intestinal transplant recipients","volume":"101","author":"Cheng","year":"2017","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.humimm.2024.110800_b0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1526924819855088","article-title":"Is there a role for desensitization in intestinal transplantation?","volume":"29","author":"Santeusanio","year":"2019","journal-title":"Prog. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2024.110800_b0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4240\/wjgs.v8.i1.101","article-title":"Successful living donor intestinal transplantation in cross-match positive recipients: Initial experience","volume":"8","author":"Garcia-Roca","year":"2016","journal-title":"World J. Gastrointest. Surg."},{"issue":"8","key":"10.1016\/j.humimm.2024.110800_b0255","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.transproceed.2021.08.008","article-title":"Temporary deceased donor splenic transplant prior to intestinal transplantation: A new strategy for desensitization?","volume":"53","author":"Spaggiari","year":"2021","journal-title":"Transplant Proc."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:03:04Z","timestamp":1781568184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0198885924000600"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110800","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in induction immunosuppression regimens for intestinal transplantation","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"110800"}}